glp-1 allodynia PDF) and Dysesthesia Associated With Semaglutide and Tirzepatide Understanding Allodynia: A Side Effect

Exendin-phe1 was clearly separated from other GLP-1R agonists (Fig

Colom C, Rull A, Sanchez-Quesada JL, Prez A (2021) Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk

Having an oral formulation, it may lower the psychological barrier that patients have to starting treatment, says Priya Jaisinghani, MD, an endocrinologist and obesity-medicine specialist at New York University Langone Medical Associates and a clinical assistant professor at NYUs Grossman School of Medicine

Clinical data suggests the drug supports meaningful weight loss and can be taken without strict food or timing requirements, potentially improving ease of use and adherence